These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28115879)

  • 1. Feasibility of Topical Applications of Natural High-Concentration Capsaicinoid Solutions in Patients with Peripheral Neuropathic Pain: A Retrospective Analysis.
    Bauchy F; Mouraux A; Deumens R; Leerink M; Ulpiano Trillig A; le Polain de Waroux B; Steyaert A; Joëlle QL; Forget P
    Pain Res Manag; 2016; 2016():9703036. PubMed ID: 28115879
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
    Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
    BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.
    Backonja M; Wallace MS; Blonsky ER; Cutler BJ; Malan P; Rauck R; Tobias J;
    Lancet Neurol; 2008 Dec; 7(12):1106-12. PubMed ID: 18977178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study.
    Maihofner C; Heskamp ML
    Curr Med Res Opin; 2013 Jun; 29(6):673-83. PubMed ID: 23551064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttraumatic and postsurgical neuropathic pain responsive to treatment with capsaicin 8% topical patch.
    Zis P; Apsokardos A; Isaia C; Sykioti P; Vadalouca A
    Pain Physician; 2014; 17(2):E213-8. PubMed ID: 24658488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of 0.625% and 1.25% Capsaicin Patch in Peripheral Neuropathic Pain: Multi-Center, Randomized, and Semi-Double Blind Controlled Study.
    Moon JY; Lee PB; Kim YC; Lee SC; Nahm FS; Choi E
    Pain Physician; 2017 Feb; 20(2):27-35. PubMed ID: 28158151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis.
    Wagner T; Poole C; Roth-Daniek A
    Pain Med; 2013 Aug; 14(8):1202-11. PubMed ID: 23710678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy Analysis of Capsaicin 8% Patch in Neuropathic Peripheral Pain Treatment.
    Tenreiro Pinto J; Pereira FC; Loureiro MC; Gama R; Fernandes HL
    Pharmacology; 2018; 101(5-6):290-297. PubMed ID: 29587275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients.
    Mou J; Paillard F; Turnbull B; Trudeau J; Stoker M; Katz NP
    Clin J Pain; 2014 Apr; 30(4):286-94. PubMed ID: 23765045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain.
    Blair HA
    Drugs; 2018 Sep; 78(14):1489-1500. PubMed ID: 30251173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Topical ambroxol for the treatment of neuropathic pain: A first clinical observation. German version].
    Kern KU; Weiser T
    Schmerz; 2015 Dec; 29(6):632-40. PubMed ID: 26597641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain.
    Haanpää M; Cruccu G; Nurmikko TJ; McBride WT; Docu Axelarad A; Bosilkov A; Chambers C; Ernault E; Abdulahad AK
    Eur J Pain; 2016 Feb; 20(2):316-28. PubMed ID: 26581442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the feasibility of high-concentration capsaicin patches in the pain unit of a tertiary hospital for a population of mixed refractory peripheral neuropathic pain syndromes in non-diabetic patients.
    Giménez-Milà M; Videla S; Navarro MA; Faulí A; Ojeda A; Bogdanovich A; Moreno LA; Hernández-Cera C; Busquets C
    BMC Anesthesiol; 2014; 14():120. PubMed ID: 25580085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical ambroxol for the treatment of neuropathic pain. An initial clinical observation.
    Kern KU; Weiser T
    Schmerz; 2015 Dec; 29 Suppl 3(Suppl 3):S89-96. PubMed ID: 26589711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study.
    Aitken E; McColl G; Kingsmore D
    Pain Med; 2017 Feb; 18(2):330-340. PubMed ID: 28204726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-concentration topical capsaicin in the management of refractory neuropathic pain in patients with neurofibromatosis type 1: a case series.
    Bardo-Brouard P; Luizard C; Valeyrie-Allanore L; Goujon C; Do B; Colin A; Wolkenstein P; Paul M
    Curr Med Res Opin; 2018 May; 34(5):887-891. PubMed ID: 29368950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of painful radiculopathies with capsaicin 8% cutaneous patch.
    Baron R; Treede RD; Birklein F; Cegla T; Freynhagen R; Heskamp ML; Kern KU; Maier C; Rolke R; Seddigh S; Sommer C; Ständer S; Maihöfner C
    Curr Med Res Opin; 2017 Aug; 33(8):1401-1411. PubMed ID: 28436279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of hyperalgesia predicts analgesic efficacy of topically applied capsaicin 8% in patients with peripheral neuropathic pain.
    Mainka T; Malewicz NM; Baron R; Enax-Krumova EK; Treede RD; Maier C
    Eur J Pain; 2016 Jan; 20(1):116-29. PubMed ID: 25854794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and outcomes of peripheral neuropathic pain patients with repeated applications of high-concentration capsaicin cutaneous patch: Results of a retrospective chart review in Germany.
    Kern KU; Quandel T; Theis S; Schubert T
    Pain Pract; 2024 Jun; 24(5):700-708. PubMed ID: 38321913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capsaicin 8% topical patch (Qutenza)--a review of the evidence.
    Jones VM; Moore KA; Peterson DM
    J Pain Palliat Care Pharmacother; 2011; 25(1):32-41. PubMed ID: 21426216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.